Position in NVS
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$1,369,419
+$25,067 QoQ
Shares Held
8,738
-0.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#530
of 1,603 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Fifth Third Wealth Advisors LLC holds $84,923,860 across 10 Drug Manufacturers - General names. NVS ranks #9 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
25,068 | $30,067,313 | |
| 2 | JNJ |
Johnson & Johnson
|
57,925 | $14,711,212 | |
| 3 | ABBV |
AbbVie Inc.
|
51,073 | $12,852,009 | |
| 4 | MRK |
Merck & Co., Inc.
|
73,198 | $9,405,943 | |
| 5 | PFE |
Pfizer Inc
|
205,404 | $4,946,128 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
33,341 | $4,212,301 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
65,413 | $3,769,097 | |
| 8 | AMGN |
Amgen Inc
|
9,260 | $3,353,231 |
All Filings in NVS
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,369,419 | 8,738 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $1,344,352 | 8,801 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $1,196,022 | 8,675 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $1,092,733 | 8,521 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $859,171 | 7,100 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $600,765 | 5,389 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $350,510 | 3,602 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $338,618 | 2,944 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $265,085 | 2,490 | Shares | Sole | 2024-07-23 | |
| No filing history on record for this holder in this stock. | ||||||